×
Please click
here
if you are not redirected within a few seconds.
All
News
Images
Videos
Maps
Shopping
Books
Search tools
Recent
Recent
Past hour
Past 24 hours
Past week
Past month
Past year
Looking Into Bio-Path Hldgs's Recent Short Interest - Bio-Path Hldgs (NASDAQ:BPTH)
Benzinga
Bio-Path Hldgs's. BPTH. short percent of float has fallen 4.27% since its last report. The company recently reported that it has 67 thousand...
1 day ago
Why Is Bio-Path (BPTH) Stock Up 89% Today?
InvestorPlace
Bio-Path stock is up with heavy trading of BPTH shares today alongside positive news from its ongoing clinical trial of BP1002.
2 weeks ago
Bio-Path (BPTH) Rises on Upbeat Updates From Blood Cancer Study
Yahoo Finance
Bio-Path (BPTH) gains 30% on encouraging developmental updates from the early-stage study of its investigational candidate, BP1002,...
2 weeks ago
Bio-Path Shares Pare Gains on Registered Direct Offering News
MarketWatch
By Josh Beckerman Bio-Path Holdings shares pared their gains after the biotechnology company announced a $1.2 million registered direct...
2 weeks ago
Synthetic Biology’s Path to Sustainable Food Systems
SynBioBeta
Synthetic biology is a remarkable set of technologies that can change our world forever. It's received a lot of hype for the amazing...
3 days ago
Bio-Path concludes first cohort of Phase I lymphoma trial
Clinical Trials Arena
Bio-Path completed the first dose cohort of the dose escalation portion of the Phase I trial of BP1002 for lymphoma and chronic lymphocytic...
3 months ago
Bio-Path Holdings Announces Consolidating Reverse Stock Split - TipRanks.com
Tipranks
Bio-Path Holdings (BPTH) has released an update. Bio-Path Holdings, Inc. has announced a 1-for-20 reverse stock split, effective February 22...
2 months ago
Bio-Path shares rally after clinical trial progress of BP1002 (NASDAQ:BPTH)
Seeking Alpha
Shares of Bio-Path Holdings (BPTH) surged over 80% on positive results from the Phase 1/1b clinical trial of BP1002.
2 weeks ago
Bio-Path Holdings shares sink 6% after deal for at-the-market offering
MarketWatch
Shares of Bio-Path Holdings fell late Thursday after the company said it had reached a deal for an at-the-market share offering.
1 month ago
When Can We Expect A Profit From Bio-Path Holdings, Inc. (NASDAQ:BPTH)?
Yahoo Finance
Expectations from some of the American Biotechs analysts is that Bio-Path Holdings is on the verge of breakeven. They anticipate the company to...
2 months ago